Severe Hypoglycemia and the Use of Glucagon Rescue Agents: An Observational Survey in Adults With Type 1 Diabetes.


Journal

Clinical diabetes : a publication of the American Diabetes Association
ISSN: 0891-8929
Titre abrégé: Clin Diabetes
Pays: United States
ID NLM: 8406985

Informations de publication

Date de publication:
2023
Historique:
medline: 17 7 2023
pubmed: 17 7 2023
entrez: 17 7 2023
Statut: ppublish

Résumé

Severe hypoglycemia (SH) is the most frequent and potentially serious complication affecting individuals with type 1 diabetes and can have major clinical and psychosocial consequences. Glucagon is the only approved treatment for SH that can be administered by non-health care professionals (HCPs); however, reports on the experiences and emotions of people with type 1 diabetes associated with SH and glucagon rescue use are limited. This survey study demonstrated that an increasing number of individuals with type 1 diabetes have current and filled prescriptions for glucagon and have been educated about glucagon rescue use by an HCP. Despite this positive trend, challenges with SH remain, including a high level of health care resource utilization, considerable out-of-pocket expenses for glucagon kits, a high prevalence of hypoglycemia unawareness, and a negative emotional impact on individuals with diabetes. Nocturnal and exercise-related hypoglycemia were concerns for most survey participants.

Identifiants

pubmed: 37456102
doi: 10.2337/cd22-0099
pii: CD220099
pmc: PMC10338275
doi:

Types de publication

Journal Article

Langues

eng

Pagination

399-410

Informations de copyright

© 2023 by the American Diabetes Association.

Déclaration de conflit d'intérêts

S.A.W. has received consulting fees from Zealand Pharma independent of the submitted work. M.W. is a former employee of Zealand Pharma. No other potential conflicts of interest relevant to this article were reported.

Références

Diabetes Technol Ther. 2020 Feb;22(2):121-130
pubmed: 31886730
Endocr Pract. 2018 Oct 2;24(10):861-866
pubmed: 30035620
Biomolecules. 2021 Aug 27;11(9):
pubmed: 34572493
Endocr Pract. 2016 Feb;22(2):123-35
pubmed: 26484405
Diabetes Educ. 2014 May;40(3):269-279
pubmed: 24695260
Pediatr Diabetes. 2018 Oct;19 Suppl 27:178-192
pubmed: 29869358
Diabet Med. 2014 Oct;31(10):1210-7
pubmed: 24824356
J Med Econ. 2015 Jun;18(6):420-32
pubmed: 25629654
Pediatr Diabetes. 2007 Dec;8(6):362-8
pubmed: 18036061
J Manag Care Spec Pharm. 2022 Apr;28(4):461-472
pubmed: 35332789
N Engl J Med. 2013 Jul 25;369(4):362-72
pubmed: 23883381
Diabetes Care. 2022 Jan 1;45(Suppl 1):S83-S96
pubmed: 34964868
J Clin Res Pediatr Endocrinol. 2021 Jan 25;13(3):285-292
pubmed: 33491925
Patient Educ Couns. 2007 Sep;68(1):10-5
pubmed: 17582726
Diabetes Technol Ther. 2019 Sep;21(9):522-530
pubmed: 31219349
J Clin Psychol Med Settings. 2011 Dec;18(4):345-52
pubmed: 21643962
Diabetes Care. 2017 Dec;40(12):1622-1630
pubmed: 29162582
Diabetes Care. 2017 Aug;40(8):1010-1016
pubmed: 28550194
Clin Diabetes. 2019 Apr;37(2):162-166
pubmed: 31057222
Exp Clin Endocrinol Diabetes. 2022 Mar;130(3):145-155
pubmed: 33368091
Exp Physiol. 2020 Apr;105(4):590-599
pubmed: 31785115
Endocr Pract. 2020 Apr;26(4):407-415
pubmed: 32293921
World J Diabetes. 2015 Oct 10;6(13):1246-58
pubmed: 26468341
Endocrinol Diabetes Nutr (Engl Ed). 2021 Oct;68(8):557-566
pubmed: 34872639
Diabetes Care. 2016 Sep;39(9):1571-8
pubmed: 27385329
Expert Rev Pharmacoecon Outcomes Res. 2013 Feb;13(1):123-30
pubmed: 23402452
Diabetes Care. 2015 Feb;38(2):316-22
pubmed: 25492401
J Diabetes Complications. 2021 May;35(5):107882
pubmed: 33593689
Ann Endocrinol (Paris). 2022 Feb;83(1):16-26
pubmed: 34871601
Can J Diabetes. 2021 Apr;45(3):236-242
pubmed: 33087294
Curr Diab Rep. 2022 Apr;22(4):189-197
pubmed: 35171447
Diabetes Care. 1994 Jul;17(7):697-703
pubmed: 7924780
Pharmacoecon Open. 2020 Sep;4(3):519-528
pubmed: 31997126
Medicine (Baltimore). 2016 Nov;95(47):e5365
pubmed: 27893672
Endocrinol Metab Clin North Am. 2013 Mar;42(1):15-38
pubmed: 23391237
Diabetes Ther. 2022 Mar;13(3):517-533
pubmed: 35199292
Diabetes Metab Syndr Obes. 2011;4:337-46
pubmed: 21969805
Diabetes Care. 2018 May;41(5):917-928
pubmed: 29567642

Auteurs

Allyson S Hughes (AS)

Department of Primary Care, Ohio University Heritage College of Osteopathic Medicine, Athens, OH.

Katherine S Chapman (KS)

T1D Exchange, Boston, MA.

Huyen Nguyen (H)

T1D Exchange, Boston, MA.

Jingwen Liu (J)

T1D Exchange, Boston, MA.

Jeoffrey Bispham (J)

T1D Exchange, Boston, MA.

Melissa Winget (M)

Zealand Pharma A/S, Boston, MA.

Stuart A Weinzimer (SA)

Department of Pediatrics, Yale School of Medicine, New Haven, CT.

Wendy A Wolf (WA)

T1D Exchange, Boston, MA.

Classifications MeSH